InvestorsHub Logo
Followers 104
Posts 2500
Boards Moderated 0
Alias Born 12/02/2016

Re: StoptheInsanity9 post# 43101

Tuesday, 09/12/2017 3:35:20 PM

Tuesday, September 12, 2017 3:35:20 PM

Post# of 95865
You need to read the financial reports again, apparently.

It is irrefutable that Roger/Plandai Biotechnology owns 90,000 Series Preferred D shares, and as I previously informed you, Roger is the majority owner. Here is the proof:

https://www.otcmarkets.com/financialReportViewer?symbol=TXTM&id=177897

Series D – Par value $0.001, 100,000 shares authorized.
As a class, the Series D Preferred can convert into that number of common shares equal to 75% of the
post-conversion issued and outstanding shares of common stock
. Individual shares of Series D Preferred
may convert into that pro-rata number of common shares equal to 1/100,000 of the total shares issuable to
the entire class. The Series D Preferred has rights voting rights equal to that number of common shares
into which the class is convertible on all shareholder matters. The Series D Preferred has no associated
dividend or pre-emptive rights. There are no other material rights of the Series D Preferred stockholders.




$TXTM